https://www.scmp.com/rss/514634/feed Junqiao Chen is a healthcare system partner at Roche, one of the world’s largest biotech companies and one of the earliest to operate in China. He has worked in various healthcare sectors in the US and Asia for almost a decade, with experience in real-world clinical research, value-based care and digital health. He is a published author in health policy, quality, and informatics in international academic journals and Hong Kong media outlets. en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com Hong Kong has finally stepped into the post-Covid-19 era. To honour those who suffered and those who fought tirelessly on the front lines, it is crucial to reflect on the lessons learned. We must scale up good practices to prepare for future pandemics, strengthen our healthcare system and establish Hong Kong’s leading position in China for biomedical innovation. Upon learning of the outbreak of Covid-19, the Department of Health announced its Preparedness and Response Plan, which directs the... https://www.scmp.com/comment/opinion/article/3213735/why-end-covid-19-era-must-mark-start-hong-kong-healthcare-reform-not-its-end?utm_source=rss_feed https://www.scmp.com/comment/opinion/article/3213735/why-end-covid-19-era-must-mark-start-hong-kong-healthcare-reform-not-its-end?utm_source=rss_feed Sat, 18 Mar 2023 00:00:14 +0000 As we look back on 2022, the Health Bureau has done a remarkable job in demonstrating its professionalism, accountability and collaborative spirit. Covid-19 is under control, and Hong Kong is open for business again. More district health centres are operating, and a primary healthcare blueprint has been released. As the city shifts its focus back to economic growth and the government redefines its development objectives, it is time to ask what the Health Bureau can do in 2023 and beyond. China’s... https://www.scmp.com/comment/opinion/hong-kong/article/3205508/bright-future-biomedical-innovation-awaits-hong-kong-right-market-conditions?utm_source=rss_feed https://www.scmp.com/comment/opinion/hong-kong/article/3205508/bright-future-biomedical-innovation-awaits-hong-kong-right-market-conditions?utm_source=rss_feed Mon, 09 Jan 2023 05:30:11 +0000